Nosocomial Pneumonia, Including Ventilator-associatedPneumonia
- 1 December 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Proceedings of the American Thoracic Society
- Vol. 2 (5) , 440-444
Abstract
Patients with nosocomial pneumonia have evidence of immunosuppression. The most obvious defect in immunity is the loss of mechanical barriers with an endotracheal tube. Only a third of colonized patients on ventilators develop pneumonia, however, suggesting that altered immunity is more extensive. This subgroup of patients tends to get multiple synchronous and sequential infections. The exact mechanisms of this compromise of immunity remain to be fully elucidated. Both a temporary immunocompromised and a specifically predisposed subpopulation, however, can explain the clinical pattern. A temporary immunoparalysis clearly occurs and is associated with increased risk of infections. An underlying genetic predisposition may lead to a predisposed population. Genetic polymorphisms in pathogen recognition molecules increase the risk of nosocomial infections. Genetic variability in immune mediators increase severity of infections and mortality but have not been demonstrated as consistently to lead to infections. Adequate treatment of an initial infection is required for reversal of the temporary immunoparalysis, whereas specific immunomodulatory therapies can reverse the markers of immunoparalysis and may decrease the risk of infection.Keywords
This publication has 46 references indexed in Scilit:
- Genetic Susceptibility to PneumoniaClinics in Chest Medicine, 2005
- The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentrationImmunology Letters, 2004
- Comparison of 8 vs 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in AdultsJAMA, 2003
- Influence of surgical intervention in the immune response of severely injured patientsIntensive Care Medicine, 2003
- Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsisIntensive Care Medicine, 2003
- Relevance of Mutations in the TLR4 Receptor in Patients With Gram-Negative Septic ShockArchives of internal medicine (1960), 2002
- RELATION OF EX VIVO STIMULATED BLOOD CYTOKINE SYNTHESIS TO POST-TRAUMATIC SEPSISCytokine, 1999
- Anti-inflammatory cytokine profile and mortality in febrile patientsThe Lancet, 1998
- In VivoEndotoxin Tolerance: Impaired LPS-Stimulated TNF Release of Monocytes from Patients with Sepsis, but Not SIRSJournal of Surgical Research, 1997
- Pneumonia Complicating Abdominal SepsisArchives of Surgery, 1991